The Pathogenesis of Systemic Sclerosis
- 28 February 2011
- journal article
- review article
- Published by Annual Reviews in Annual Review Of Pathology-Mechanisms Of Disease
- Vol. 6 (1), 509-537
- https://doi.org/10.1146/annurev-pathol-011110-130312
Abstract
Systemic sclerosis (SSc), also known as scleroderma, is a rare connective tissue disease characterized by vascular and immune dysfunction, leading to fibrosis that can damage multiple organs. Its pathogenesis is complex and poorly understood. Two major clinical subtypes are the limited and diffuse forms. Research into SSc has been hampered by its rarity, its clinical heterogeneity, and the lack of mouse models that accurately recapitulate the disease. Clinical and basic studies have yielded some mechanistic clues regarding pathogenesis. Recent insights gained through the use of microarrays have revealed distinctive subsets of SSc within and beyond the limited and diffuse subsets. In this review, we discuss potential mechanisms underlying the vascular, autoimmune, and fibrotic points of dysregulation. Proper categorization of SSc patients for research studies by use of microarrays or other biomarkers is critical, as disease heterogeneity may explain some of the inconsistencies of prior studies.Keywords
This publication has 101 references indexed in Scilit:
- Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locusNature Genetics, 2010
- Systemic sclerosis and lupus: Points in an interferon‐mediated continuumArthritis & Rheumatism, 2010
- A four‐gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosisArthritis & Rheumatism, 2010
- HLA–DPB1 and DPB2 are genetic loci for systemic sclerosis: A genome‐wide association study in Koreans with replication in North AmericansArthritis & Rheumatism, 2009
- B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosisArthritis & Rheumatism, 2009
- Molecular framework for response to imatinib mesylate in systemic sclerosisArthritis & Rheumatism, 2009
- Identification of candidate genes in scleroderma-related pulmonary arterial hypertensionTranslational Research, 2008
- T cell polarization identifies distinct clinical phenotypes in scleroderma lung diseaseArthritis & Rheumatism, 2008
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Vascular damage and lack of angiogenesis in systemic sclerosis skinClinical Rheumatology, 2003